These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18381904)

  • 1. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
    Mannuzza S; Klein RG; Truong NL; Moulton JL; Roizen ER; Howell KH; Castellanos FX
    Am J Psychiatry; 2008 May; 165(5):604-9. PubMed ID: 18381904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
    Biederman J; Monuteaux MC; Spencer T; Wilens TE; Macpherson HA; Faraone SV
    Am J Psychiatry; 2008 May; 165(5):597-603. PubMed ID: 18316421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study.
    Mannuzza S; Klein RG; Moulton JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):273-82. PubMed ID: 14642015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants.
    Lambert NM; Hartsough CS
    J Learn Disabil; 1998; 31(6):533-44. PubMed ID: 9813951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
    Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
    Harty SC; Ivanov I; Newcorn JH; Halperin JM
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):331-9. PubMed ID: 21823914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for more than 3 years' duration of central stimulant treatment in adult attention-deficit/hyperactivity disorder: a retrospective, naturalistic study.
    Torgersen T; Gjervan B; Nordahl HM; Rasmussen K
    J Clin Psychopharmacol; 2012 Oct; 32(5):645-52. PubMed ID: 22926598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there stimulant sensitivity in children?
    Klein R; Mannuzza S
    J Atten Disord; 2002; 6 Suppl 1():S61-3. PubMed ID: 12685520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.
    Schrantee A; Bouziane C; Bron EE; Klein S; Bottelier MA; Kooij JJS; Rombouts SARB; Reneman L
    Brain Imaging Behav; 2018 Apr; 12(2):402-410. PubMed ID: 28321605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.